Oncology and Hematology

1-16 of 597

Smarter Screening for Non-Small Cell Lung Cancer
Smarter Screening for Non-Small Cell Lung Cancer
Project Oncology®
Smarter Screening for Non-Small Cell Lung Cancer
- Jobelle Baldonado, MD
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
AudioAbstracts
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
- Ryan Quigley
Cosibelimab Delivers Durable Responses in Advanced CSCC
Cosibelimab Delivers Durable Responses in Advanced CSCC
Project Oncology®
Cosibelimab Delivers Durable Responses in Advanced CSCC
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Project Oncology®
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Recognizing High-Risk Profiles for NSCLC
Recognizing High-Risk Profiles for NSCLC
Project Oncology®
Recognizing High-Risk Profiles for NSCLC
- Jobelle Baldonado, MD
Oncogenic Drivers in Never-Smokers with NSCLC
Oncogenic Drivers in Never-Smokers with NSCLC
Project Oncology®
Oncogenic Drivers in Never-Smokers with NSCLC
- Apar Kishor Ganti, MD, MS
Expanding Molecular Testing in Community NSCLC Care
Expanding Molecular Testing in Community NSCLC Care
Project Oncology®
Expanding Molecular Testing in Community NSCLC Care
- Apar Kishor Ganti, MD, MS
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Project Oncology®
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
- Brian P. McDonough, MD, FAAFP
- Tara Graff, DO, MS
- Surbhi Sidana, MD
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
Project Oncology®
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
- Brian P. McDonough, MD, FAAFP
- Christopher T. Chen, MD
Optimizing Care for Older Adults With FLT3-Mutated AML
Optimizing Care for Older Adults With FLT3-Mutated AML
Global Oncology Academy
Optimizing Care for Older Adults With FLT3-Mutated AML
- Ryan Quigley
- Nicholas Short, MD
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
- Maxwell Llyod, MD
- Ryan Quigley
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Project Oncology®
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
AudioAbstracts
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
- Ryan Quigley
Bridging Gaps with Blood-Based CRC Screening
Bridging Gaps with Blood-Based CRC Screening
Global Oncology Academy
Bridging Gaps with Blood-Based CRC Screening
- Ryan Quigley
- Aasma Shaukat, MD, MPH
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
Global Oncology Academy
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
- Ryan Quigley
- Thomas Cataldo, MD
- Sowmya Sharma, MD
Prioritizing Quality of Life in CRC: Key Surgical Considerations
Prioritizing Quality of Life in CRC: Key Surgical Considerations
Global Oncology Academy
Prioritizing Quality of Life in CRC: Key Surgical Considerations
- Ryan Quigley
- Thomas Cataldo, MD
- Sowmya Sharma, MD